During tumor progression, TGFβ may induce an epithelial-to-mesenchymal transition (EMT) in cancer cells, a process through which cancer cells acquire mesenchymal phenotypes associated with invasion and metastasis, while bypassing the tumor-suppressive functions of epithelial TGFβ signaling [15,16]. This evidence concerns the gene TGFB1 and cancer.